Generis Knowledge Management announced today that they will be making their CARA Platform available for free to companies globally who are manufacturing and providing ventilators to help with treatment of Covid-19.
Generis is reaching out to companies who are involved with the production of ventilators. The CARA platform is one of the leading platforms for authoring and managing medical/medicinal product information and documentation for health authority approval, and is currently used by many of the world’s largest Life Science companies.
“We see the efforts of companies like Dyson, Airbus, and Rolls Royce, as well as smaller, absolutely tenacious companies taking huge business risks to support the initiatives to get these ventilators to the NHS and other health services.“ said Max Kelleher, COO of Generis.
“I am proud of our company’s decision to donate our software, time, and perhaps most valuably in the cases of less experienced companies, our knowledge, to these businesses. We are working with our partners to do the same to the degree that they can, even if that means just donating some limited hours from knowledgeable consultants.”
Ventilator manufacturing companies can benefit from CARA in a number of different ways, for example managing compliant documentation, product information, and submissions for Health Authority Approval locally or globally.
Generis are encouraging businesses to get in touch at this time.
Generis is a global leader in content and information management systems, specialising in proven solutions for regulated industries. Established in 1997 as a consultancy group, Generis has since grown and developed alongside its flagship product CARA. Our mission is to provide a solution which is highly configurable and user friendly; a dedicated team works hard to guarantee customer satisfaction. Currently counting over 450,000 users across numerous industries worldwide, including 8 of the 10 largest Life Science companies, CARA continues to progress to become the answer for end to end data management.
To find out more visit : https://www.generiscorp.com